Seasonal Affective Disorder Therapeutics Market: Rising Adoption of Bright Light Therapy to Drive Growth: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • Published: 2019-02-13
  • Report Code: REP-GB-8821

An Incisive, In-depth Analysis on the Seasonal Affective Disorder Therapeutics Market

This study offers a comprehensive, 360 degree analysis on the Seasonal Affective Disorder Therapeutics market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Seasonal Affective Disorder Therapeutics market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Physicians are Increasingly Recommending Bright Light Therapy

It has been noted that physicians across the globe are increasingly recommending Bright Light Therapy (BLT) as a prophylactic measure for Seasonal Affective Disorder Therapeutics. BLT provides a robust, rapid and completely anti-depressant effect. The therapy onset should be typically within four days of Seasonal Affective Disorder.  Monitoring should be done on a phase resetting basis on timed effects of introduction of bright light. The dosage of light therapy can be titrated against side effects and patients can easily avoid drug-drug interactions. Use of bright light therapy in self-reporting population and sub-syndromal disease impacted population is a clear way to boost revenue visibility for Seasonal Affective Disorder Therapeutics market over the forecast period.

External Factors Impact Treatment Decisiveness Among Physicians

There are several external factors that impact treatment decisiveness among physicians for seasonal affective disorder. These include patient expectations, disease history and stability, risk/benefit ratio and lastly, lack of evidence. Apart from willingness of patients, there are six other traits that impact the Seasonal Affective Disorder Therapeutics uptake and adherence rates among patients suffering from seasonal affective disorder. These include awareness about disease and available preventive treatment options, prognostic experience with treatment in acute phase of the disease, acceptability of suggestive medical interventions and absolute willingness to take responsibility for oneself after the medical intervention has begun. Culmination of all above mentioned factors actually impacts the Seasonal Affective Disorder Therapeutics decisiveness among physicians. This trend is likely to impact the revenue generation ability of available options for Seasonal Affective Disorder Therapeutics, positively as adherence in long term is directly proportional to increased patient awareness and acceptance.

 

Improper Treatment Management Can Backfire and Lead to Serious Side Effects

Experts have noted that improper Seasonal Affective Disorder Therapeutics can have serious side effects and lead to a significant dip in adoption rates of Seasonal Affective Disorder Therapeutics. To stop these side effects of Seasonal Affective Disorder Therapeutics, the dosage should be reduced, stopped and re-challenged after two to three days. In this regard, it’s worth noting that adjunctive light therapy should begin with a dose titration of 7,000 lux, 4000 K blue enriched broad spectrum white light for 15 minutes per day at midday around 2.30pm in the noon. Then 15 minutes should be added each subsequent week till the dosage reaches a range of 45-60 minutes per day. Average time to response and remission varies between four and six weeks normally. Continuous patient-physician engagement leads to better Seasonal Affective Disorder Therapeutics.

Availability of Broad Options for Treatment

A wide range of options are available in the market for Seasonal Affective Disorder Therapeutics. Both drugs and devices are available in the market for Seasonal Affective Disorder Therapeutics. Light therapy is used as the first line of therapy for the Seasonal Affective Disorder Therapeutics. A wide range of devices, such as light boxes, desk lamps, dawn stimulators and sun visors are available in the market as light therapy for Seasonal Affective Disorder Therapeutics. Both branded and generic drugs for Seasonal Affective Disorder Therapeutics are available in developed and developing economies. Citalopram and Buproban are commonly used drugs for the Seasonal Affective Disorder Therapeutics. Also, a wide number of generic options for Citalopram and Buproban are available in the market for Seasonal Affective Disorder Therapeutics. Therefore, easy availability of broad options for Seasonal Affective Disorder Therapeutics will boost the revenue growth of the market. 

Competitive Landscape

The competition section of the Seasonal Affective Disorder Therapeutics market report features the profiles of key players in the Seasonal Affective Disorder Therapeutics market based on their product offerings, market shares, marketing approach and differential strategies. Some of the key players profiled in the Seasonal Affective Disorder Therapeutics market report include Allergan plc., Eli Lily Company, GlaxoSmithKline plc,  Pfizer Inc., Teva Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., The Sunbox Company,  Verilux, Inc., Carex Health, Northern Light Technologies, Beurer GmbH and Koninklijke Philips N.V.

Definition

Seasonal affective disorder (SAD) is a category of depression that emerges in particular seasons of the year.  Most people notice SAD symptoms starting in the fall and these symptoms increase during the winter months, but a few people also experience the spring and summer version. The symptoms of Seasonal affective disorder (SAD) includes heaviness in arms and legs, frequent oversleeping, cravings for carbohydrates, weight gain and others.

About the Report

FMI has conducted a research study on the Seasonal Affective Disorder Therapeutics market for the forecast period 2018 to 2028. The Seasonal Affective Disorder Therapeutics market report offers a comprehensive evaluation of the business opportunities prevailing in the Seasonal Affective Disorder Therapeutics market, along with insights on pipeline assessment, key regulations and reimbursement scenario. The report on the Seasonal Affective Disorder Therapeutics market also elaborates on the macro-economic factors influencing the dynamics in the Seasonal Affective Disorder Therapeutics market.

Segmentation

The report offers a comprehensive taxonomy of the Seasonal Affective Disorder Therapeutics market based on treatment type, disorder type, distribution channel and region. The options used as Seasonal Affective Disorder Therapeutics, such as device and drugs, have been studied in this report. Devices used for Seasonal Affective Disorder Therapeutics includes light boxes, dawn stimulators, desk lamps and sun visors. Drug types prescribed for Seasonal Affective Disorder Therapeutics include SSRIs, SNRIs, NDRIs, TCAs and MOAIs. Both Unipolar and Bipolar seasonal affective disorders were taken into consideration during the course of study. The Distribution channel segment of the Seasonal Affective Disorder Therapeutics market has been classified into institutional sales and retail sales. The Seasonal Affective Disorder Therapeutics market has been analysed across regions of North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA.

Additional Questions Answered

Some of the additional questions addressed in this report on Seasonal Affective Disorder Therapeutics market are:

  • What is the revenue potential of drugs and devices used for Seasonal Affective Disorder Therapeutics across regions of North America and Europe?

  • Who are the key competitors in the Seasonal Affective Disorder Therapeutics market and what are their product portfolios and growth strategies?

  • What are the major factors influencing the growth of the Seasonal Affective Disorder Therapeutics market?

  • Which trends are being followed by the leading manufacturers to retain their market share?

  • What is the prevalence and treatment-seeking rate for Seasonal Affective Disorder Therapeutics in the top countries?

A recent market study published by FMI– “Seasonal Affective Disorder Therapeutics Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028” consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research of the historic as well as current growth parameters of the Seasonal Affective Disorder Therapeutics market, the growth prospects are obtained with maximum precision. The Seasonal Affective Disorder Therapeutics market report features the unique and salient factors that are likely to significantly impact the development of the Seasonal Affective Disorder Therapeutics market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Seasonal Affective Disorder Therapeutics market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Seasonal Affective Disorder Therapeutics market in the most comprehensive manner for the better understanding of readers.

Chapter 1 – Executive Summary

The Seasonal Affective Disorder Therapeutics market report commences with an executive summary of the key findings and key statistics of the Seasonal Affective Disorder Therapeutics market. It also includes the market value (US$ million) estimates of the leading segments of the Seasonal Affective Disorder Therapeutics market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the Seasonal Affective Disorder Therapeutics market in this chapter, which helps understand the basic information about the Seasonal Affective Disorder Therapeutics. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the Seasonal Affective Disorder Therapeutics market report.

Chapter 3 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the Seasonal Affective Disorder Therapeutics market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the Seasonal Affective Disorder Therapeutics market. This chapter also highlights the key dynamics of the Seasonal Affective Disorder Therapeutics market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the Seasonal Affective Disorder Therapeutics market.

Chapter 4 – Key Success Factors

This chapter highlights the key success factors of the Seasonal Affective Disorder Therapeutics market report, which include key regulations, disease epidemiology and comprehensive list of FDA approved light therapy devices. The key regulations section of this chapter highlights the FDA and EMA regulatory processes for the approval of drugs and devices. Disease epidemiology highlights the prevalence rate and treatment seeking rate of seasonal affective disorder.

Chapter 5 – Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2017 & Opportunity Assessment 2018-2028

This section explain the global market volume analysis and forecast for the Seasonal Affective Disorder Therapeutics market. The sale of different types of devices for Seasonal Affective Disorder Therapeutics for every year between the forecast periods of 2013-2028 is highlights in this section.

Chapter 6 – Global Seasonal Affective Disorder Therapeutics Market: Pricing Analysis

This section highlights the average price of light boxes, dawn stimulator, desk lamps and sun visor in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.

Chapter 7 – Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2017 & Opportunity Assessment 2018-2028

This section explain the global market analysis and forecast for the Seasonal Affective Disorder Therapeutics market. It also highlights the incremental opportunity for the Seasonal Affective Disorder Therapeutics market along with the absolute dollar opportunity for every year between the forecast period of 2018-2028.  

Chapter 8 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Treatment Type

Based on the treatment type, the Seasonal Affective Disorder Therapeutics market Drugs and devices. In this chapter, readers can find a detailed analysis of the Seasonal Affective Disorder Therapeutics market by different treatment types and their expected growth over the forecast period.

Chapter 9 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Disorder Type

Based on the Disorder Type, the Seasonal Affective Disorder Therapeutics market is segmented as unipolar disorder and bipolar disorder. This section helps readers understand the penetration of both disorder type in the Seasonal Affective Disorder Therapeutics market over the forecast period.

Chapter 10 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Distribution Channel

Based on the distribution channel, the Seasonal Affective Disorder Therapeutics market is segmented into retail sales and institutional sales. In this chapter, readers can understand the market attractive analysis based on the distribution channel.

Chapter 11 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Region

This chapter explains how the Seasonal Affective Disorder Therapeutics market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa (MEA).

Chapter 12 – North America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes a detailed analysis of the growth of the North America Seasonal Affective Disorder Therapeutics market along with a country-wise assessment, which includes the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, disorder type, distribution channel and country of Seasonal Affective Disorder Therapeutics in the North America region.

Chapter 13 – Latin America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter contains a snapshot of the Latin America Seasonal Affective Disorder Therapeutics market. It includes the growth prospects of the Seasonal Affective Disorder Therapeutics market in the leading LATAM countries such as Brazil, Mexico, Argentina and the rest of the Latin America region.

Chapter 14 – Europe Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

The important growth prospects of the Seasonal Affective Disorder Therapeutics market based on its radionuclide type, indication and distribution channel in several European countries, such as the U.K., Germany, France, Italy Spain, Russia and the rest of Western Europe, is included in this chapter.

Chapter 15 – East Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter highlights the growth of the Seasonal Affective Disorder Therapeutics market in Eastern Europe by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the Seasonal Affective Disorder Therapeutics market in East Asia.

Chapter 16 – South Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia Seasonal Affective Disorder Therapeutics market in this chapter. Readers can find detailed information about the growth parameters of the South Asia Seasonal Affective Disorder Therapeutics market during the period 2018-2028.

Chapter 17 – Oceania Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find important factors that can significantly impact the growth of the Seasonal Affective Disorder Therapeutics market in Australia and New Zealand during the forecast period based on the market segmentation.

Chapter 18 – MEA Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter provides information about the growth of the Seasonal Affective Disorder Therapeutics market in the major countries of the MEA region, such as GCC Countries and South Africa, during the period 2018-2028.

Chapter 19 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the Seasonal Affective Disorder Therapeutics market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, recent company developments. Some of the players featured in the Seasonal Affective Disorder Therapeutics market report are Allergan plc., Eli Lily Company, GlaxoSmithKline plc,  Pfizer Inc., Teva Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., The Sunbox Company,  Verilux, Inc., Carex Health, Northern Light Technologies, Beurer GmbH, and Koninklijke Philips N.V.

Chapter 20 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the Seasonal Affective Disorder Therapeutics market.

Seasonal Affective Disorder Therapeutics Market Reports - Table of Contents

Seasonal Affective Disorder Therapeutics Market Reports - List of Tables

  1.  Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type 

  2.  Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type 

  3.  Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Disorder Type

  4.  Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Distribution Channel 

  5.  Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region

  6.  North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  7.  North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  8.  North America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  9.  North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  10.  North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  11.  Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  12.  Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  13.  Latin America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  14.  Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  15.  Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  16.  Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  17.  Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  18.  Europe Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  19.  Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  20.  Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  21.  South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  22.  South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  23.  South Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  24.  South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  25.  South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  26.  East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  27.  East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  28.  East Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  29.  East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  30.  East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  31.  Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  32.  Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  33.  Oceania Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  34.  Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  35.  Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  36.  MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country

  37.  Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  38.  MEA Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  39.  MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  40.  MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  41.  China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  42.  China Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  43.  China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  44.  China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  45.  Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  46.  Russia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  47.  Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  48.  Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

  49.  Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type

  50.  Indonesia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type

  51.  Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type

  52.  Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

Seasonal Affective Disorder Therapeutics Market Reports - List of Figures

  1.  Global Seasonal Affective Disorder Therapeutics Market Volume Analysis (‘000 Units), By Devices, 2013-2017

  2.  Global Seasonal Affective Disorder Therapeutics Market Volume Forecast (‘000 Units), By Devices, 2018-2028

  3.  Light Boxes, Pricing Analysis  per unit (US$), By Region, 2017

  4.  Light Boxes, Pricing Analysis  per unit (US$), By Region, 2028

  5.  Dawn Stimulator, Pricing Analysis  per unit (US$), By Region, 2017

  6.  Dawn Stimulator, Pricing Analysis  per unit (US$), By Region, 2028

  7.  Desk Lamp, Pricing Analysis  per unit (US$), By Region, 2017

  8.  Desk Lamp, Pricing Analysis  per unit (US$), By Region, 2028

  9.  Sun Visors , Pricing Analysis  per unit (US$), By Region, 2017

  10.  Sun Visors , Pricing Analysis  per unit (US$), By Region, 2028

  11.  Global Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  12.  Global Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  13.  Global Seasonal Affective Disorder Therapeutics Market Absolute $ Opportunity, 2018 - 2028

  14.  Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Treatment Type, 2018 & 2028

  15.  Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Treatment Type, 2018-2028

  16.  Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  17.  Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Disorder Type, 2018 & 2028

  18.  Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Disorder Type, 2018-2028

  19.  Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  20.  Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Distribution Channel, 2018 & 2028

  21.  Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2028

  22.  Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  23.  Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Region, 2018 & 2028

  24.  Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Region, 2018-2028

  25.  Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Region, 2018-2028

  26.  North America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  27.  North America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  28.  North America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  29.  North America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  30.  North America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  31.  North America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  32.  North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  33.  North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  34.  North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  35.  North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  36.  Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  37.  Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  38.  Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  39.  Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  40.  Latin America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  41.  Latin America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  42.  Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  43.  Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  44.  Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  45.  Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  46.  Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  47.  Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  48.  Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  49.  Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  50.  Europe Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  51.  Europe Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  52.  Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  53.  Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  54.  Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  55.  Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  56.  South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  57.  South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  58.  South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  59.  South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  60.  South Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  61.  South Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  62.  South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  63.  South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  64.  South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  65.  South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  66.  East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  67.  East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  68.  East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  69.  East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  70.  East Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  71.  East Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  72.  East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  73.  East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  74.  East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  75.  East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  76.  Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  77.  Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  78.  Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  79.  Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  80.  Oceania Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  81.  Oceania Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  82.  Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  83.  Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  84.  Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  85.  Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  86.  MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)

  87.  MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)

  88.  MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)

  89.  MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)

  90.  MEA Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  91.  MEA Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  92.  MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028

  93.  MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028

  94.  MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028

  95.  MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028

  96.  Global Seasonal Affective Disorder Therapeutics Market Value Proportion Analysis, By Emerging Countries, 2018

  97.  Seasonal Affective Disorder Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028

  98.  China Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  99.  China Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  100.  Russia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  101.  Russia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

  102.  Indonesia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017

  103.  Indonesia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology